Elevar Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Elevar Therapeutics's estimated annual revenue is currently $21.9M per year.(i)
  • Elevar Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Elevar Therapeutics has 109 Employees.(i)
  • Elevar Therapeutics grew their employee count by 45% last year.

Elevar Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief People OfficerReveal Email/Phone
3
Marketing DirectorReveal Email/Phone
4
Sr Director, ControllerReveal Email/Phone
5
Senior Director Global Alliance ManagementReveal Email/Phone
6
Director Quality AssuranceReveal Email/Phone
7
Chief Medical OfficerReveal Email/Phone
8
Executive Director, Commercial OperationsReveal Email/Phone
9
Sr. DirectorReveal Email/Phone
10
Executive Director, Medical ResourcesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.2M465%N/AN/A
#2
$17.3M864%N/AN/A
#3
$20.5M102-1%N/AN/A
#4
$7.6M38-3%N/AN/A
#5
$14.9M7437%N/AN/A
#6
$10.7M53-9%N/AN/A
#7
$6.2M317%N/AN/A
#8
$6.8M3413%N/AN/A
#9
$5.4M27-36%N/AN/A
#10
$305.9M15228%N/AN/A
Add Company

What Is Elevar Therapeutics?

Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. Our experience is rooted in oncology, and we apply the same rigor and diligence that comes with this knowledge to identifying and developing promising medicines for complex yet under-treated health conditions across a range of therapeutic areas. We develop and assess therapeutics based upon their ability to make a meaningful impact for patients and their treatment experiences. We invest in proven and promising therapeutics at various stages of development and advance them through clinical and regulatory processes with the goal of commercializing improved treatment options for patients and the healthcare providers who treat them. Elevating Outcomes: We take a relentless and inventive approach towards developing and advancing next generation, best-in-class therapies that have the potential to set new standards of care and improve treatment experiences. Evolving Therapeutic Potential: We identify areas where we can develop, build upon or evolve medicines that offer patients improved clinical outcomes. Engaging with Purpose: We are committed to engaging with the highest ethical standards, driven by a passion to address the underserved needs of patients, caregivers and healthcare providers. Elevar's corporate values are the essential tenets that define who we are and what we stand for. They guide us in our relationships with each other, in how we work and communicate, and ultimately how we will achieve our mission. Trust * Collaborative * Relentless * Brave * Accountable

keywords:N/A

N/A

Total Funding

109

Number of Employees

$21.9M

Revenue (est)

45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Elevar Therapeutics News

2022-03-30 - Testing for High-Risk Human Papillomavirus in Lower Genital ...

... Gradalis, Karyopharm Therapeutics, Sorrento Therapeutics, Novocure, Bayer, Elevar Therapeutics, EMD Merck, Gradalis, US Oncology.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M10940%N/A
#2
$31.6M10951%N/A
#3
$23.1M1107%N/A
#4
$29.7M1106%N/A
#5
$26M1116%N/A